The FDA just approved Foundayo, a new once-daily oral GLP-1 weight-loss medication — and it could dramatically expand access to obesity treatment because it removes the need for injections and strict dosing routines.
But the biggest question isn’t:
“How much weight can this pill help you lose?”
The real question is:
Will it help you keep the weight off — and protect your metabolism long term?
In this week’s Biohacker Bulletin, I break down:
What Foundayo actually is (and how it differs from injectable GLP-1 medications)
Why oral GLP-1 drugs could reshape weight-loss treatment
What clinical trials really showed about expected weight loss (~12% average body weight)
The overlooked muscle-loss risk many GLP-1 users never hear about
Why convenience does not equal metabolic protection
The habit-based strategy professionals need if they want lasting results
Foundayo may make GLP-1 treatment easier to start.
But without the right strategy, it won’t make transformation easier to sustain.
Watch the full breakdown above.
Here’s How To MAXIMIZE Your GLP-1 Experience for (100% FREE)
Discover the 10 evidence-based optimization factors I have successfully used with my GLP-1 coaching clients. Incorporate them…They work!
